SEGALL BRYANT & HAMILL, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 237 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2020. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
SEGALL BRYANT & HAMILL, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$4,778,433
-21.0%
95,150
-0.6%
0.06%
-12.7%
Q2 2023$6,048,936
+141164.3%
95,711
+0.6%
0.06%
+37.0%
Q1 2023$4,282
-46.5%
95,180
-47.9%
0.05%
-48.3%
Q4 2022$8,002
-99.9%
182,660
-12.4%
0.09%
-45.7%
Q3 2022$13,748,000
+33.3%
208,631
+2.2%
0.16%
+41.4%
Q2 2022$10,310,000
-8.0%
204,188
+16.4%
0.12%
+8.4%
Q1 2022$11,208,000
+77.8%
175,436
+198.2%
0.11%
+84.5%
Q4 2021$6,302,000
-29.3%
58,834
-32.1%
0.06%
+34.9%
Q3 2021$8,908,000
+140.0%
86,672
+105.4%
0.04%
+19.4%
Q2 2021$3,712,000
-3.7%
42,190
+6.5%
0.04%
-5.3%
Q1 2021$3,853,000
-14.8%
39,633
-1.7%
0.04%
-24.0%
Q4 2020$4,523,000
+18.8%
40,334
-1.8%
0.05%
-3.8%
Q3 2020$3,808,000
+330.3%
41,083
+262.7%
0.05%
+246.7%
Q2 2020$885,000
+37.9%
11,328
+3.1%
0.02%
+15.4%
Q1 2020$642,000
-33.7%
10,988
-9.1%
0.01%
-13.3%
Q4 2019$968,00012,0820.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders